DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* MEDESIS PHARMA *


 

2003 - Langeudoc-Roussillon
Baillargues
(near Montpellier)
www.medesispharma.com

 

Discovery, Drugs
Key words: Nanotechnology drug delivery systems, Metals low doses, Vanadium, Manganese, Strontium, Metabolic syndrome, Diabetes, Huntington Disease, Bipolar Disorders
Mission: to develop new innovative treatments of diabetes and neurodegenerative disorders based on metallic ions technology and delivery of nucleic acid (siRNA antisens)
Clients: undisclosed
contact@medesispharma.com

Age: 14 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Maurel (Jean-Claude) [founder, born 1946, M.D., M.Sc., ex-Natura Medica (founder)]
Sc.Dir.-CSO: Maurel (Patrick) [Ph.D., ex-Inserm]
Oper.Dir.-COO: Jackson (Peter) [Ph.D.]
Fin.Dir.-CFO:
BusDev: Jackson (Peter)
Financers (Hist.): privately owned

Turnover (M€) : 0.008 (2011), 0.013 (2008), 0.085 (2007)
Total funding (M€) : 8.5
Last funding (M€) : 2.7
Focus : Multiple
Position : Clinical
Company confirm : 2-May-2011

 

History
DATEMILESTONETYPETIME
2011 .06 Clinical trial (phase IIa) for NP03 in bipolar disorders (beginning) CLIN [8 years]
2011 .01 Clinical trial (phase I) for disease modifying treatment for Huntington’s disease NP03 (completed, published in August 2012) CLIN [7 years]
2010 .05 Clinical trial (phase I) for anti-diabetic NP01 (completed) CLIN [7 years]
2009 .12 Registration : orphan Drug positive opinion by EMEA for treatment of Huntington's disease (NP03) MKTG [6 years]
2008 .04 Financing (no interest loan) : 0.9 M€, by OSEO and Languedoc-Roussillon region, to support its ongoing program for NP01 in diabetes DEBT [5 years]
2008 .01 Company move from Paris to Baillargues (10km from Montpellier) ORGL [4 years]
2006 .01 Clinical trial planned, after first preclinical trial results on NP01 on metabolic syndrome CLIN [2 years]
2003 .04 Company founded by Jean-Claude Maurel, headquartered in Baillargues (today : labs location) ORGF [0 year]

Actualisation / Updating: 18-Nov-2012

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende